Indo US Bio-Tech Ltd

Indo US Bio-Tech Ltd, a player in the Other Agricultural Products sector, touched a fresh 52-week low of Rs.110.15 today, marking a significant decline amid broader market weakness and sector underperformance. The stock’s fall reflects ongoing pressures despite some underlying financial strengths.

Indo US Bio-Tech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 05 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 12 January 2026, providing investors with the most up-to-date view of the company’s performance and outlook.

Indo US Bio-Tech Ltd has seen its investment rating upgraded from Sell to Hold as of 29 Dec 2025, reflecting a nuanced improvement in technical indicators, valuation metrics, and financial trends despite recent flat quarterly performance. This shift highlights a cautious optimism among analysts amid ongoing market challenges and the company’s attractive long-term fundamentals.

Indo US Bio-Tech, a player in the Other Agricultural Products sector, is currently navigating a complex market environment marked by subdued financial results, shifting technical indicators, and valuation contrasts. Recent assessment changes reflect a nuanced view of the company’s prospects amid broader market dynamics.

Indo US Bio-Tech, a microcap player in the Other Agricultural Products sector, has experienced a revision in its market evaluation metrics, reflecting nuanced shifts across quality, valuation, financial trends, and technical outlook. This adjustment comes amid a backdrop of mixed financial performance and subdued stock returns over the past year.

Indo US Bio-Tech Ltd witnessed a remarkable trading session on 26 Nov 2025, hitting its upper circuit limit with a near 20% gain. The stock's surge was driven by intense buying interest, resulting in a regulatory freeze on further transactions and highlighting significant unfilled demand in the market.

Indo US Bio-Tech Ltd witnessed extraordinary buying momentum on 26 Nov 2025, registering a remarkable 19.98% gain in a single trading session. The stock's price action was characterised by an upper circuit scenario with exclusively buy orders in the queue, signalling intense demand and a potential multi-day circuit continuation.

Indo US Bio-Tech has reached a new 52-week low of Rs.112.6, marking a significant decline in its stock price amid broader market gains and sectoral advances. The stock's recent performance contrasts sharply with the positive momentum observed in the agricultural sector and the wider market indices.

Indo US Bio-Tech's stock reached a fresh 52-week low of Rs.112.6 today, marking a significant decline amid broader market gains and sectoral strength. The stock's recent performance contrasts sharply with the overall positive momentum in the agricultural products sector and the wider market indices.

Indo US Bio-Tech has reached a new 52-week low of Rs.112.6, marking a significant decline amid broader market gains and sectoral strength. The stock’s recent performance contrasts sharply with the positive momentum seen in the agricultural sector and the broader Sensex index.

Indo US Bio-Tech’s stock price reached a new 52-week low of Rs.112.6 today, marking a significant decline amid broader market gains and sectoral strength. The stock’s recent performance contrasts sharply with the positive momentum seen in the agricultural products sector and the wider market indices.

Indo US Bio-Tech has reached a new 52-week low of Rs.112.6, marking a significant decline as the stock continues to lag behind its sector and broader market indices. This development comes amid subdued quarterly results and a persistent downtrend over recent sessions.

Indo US Bio-Tech has reached a new 52-week low of Rs.112.6, marking a significant decline in its share price amid broader market gains and sectoral strength. The stock's recent performance contrasts sharply with the positive trends seen in the agricultural sector and the broader Sensex index.

Indo US Bio-Tech's stock price reached a fresh 52-week low of Rs.117.8 today, marking a significant decline amid a volatile trading session. The stock underperformed its sector and broader market indices, reflecting ongoing pressures within the company’s financial performance and market positioning.